Pathstone Holdings’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Sell
33,551
-7,903
-19% -$366K ﹤0.01% 1240
2026
Q1
$1.82M Sell
41,454
-5,238
-11% -$239K 0.01% 1080
2025
Q4
$2.07M Sell
46,692
-1,479
-3% -$63.7K 0.01% 1011
2025
Q3
$2.03M Sell
48,171
-1,465
-3% -$59.1K 0.01% 1016
2025
Q2
$1.82M Buy
49,636
+9,842
+25% +$365K 0.01% 1059
2025
Q1
$1.52M Buy
39,794
+413
+1% +$15.4K 0.01% 1143
2024
Q4
$1.49M Buy
39,381
+7,269
+23% +$290K 0.01% 1143
2024
Q3
$1.31M Buy
32,112
+6,199
+24% +$235K 0.01% 1223
2024
Q2
$888K Buy
25,913
+7,015
+37% +$221K ﹤0.01% 1389
2024
Q1
$598K Buy
18,898
+1,729
+10% +$52.6K ﹤0.01% 1591
2023
Q4
$526K Buy
+17,169
New +$551K ﹤0.01% 1476

Other funds holding OHI

Pathstone Holdings's OHI Position: Q2 2026 in Review

Pathstone Holdings reduced its Omega Healthcare (OHI) stake by 19% in Q2 2026, selling an estimated $366K and leaving 33,551 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

Pathstone Holdings first reported a position in OHI in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.07M in Q4 2025. 759 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Pathstone Holdings held 33,551 shares of Omega Healthcare worth $1.6M as of Q2 2026.
  • Pathstone Holdings sold 7,903 Omega Healthcare shares in Q2 2026, an estimated $366K.
  • Omega Healthcare made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1240 holding.
  • Pathstone Holdings first reported a position in Omega Healthcare in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Omega Healthcare position peaked at $2.07M in Q4 2025.
  • 759 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.